Award Winning Actress Sheryl Lee Ralph Joins Change the Pattern Initiative as a Celebrity Ambassador to Reimagine the Fight to End HIV/AIDS in the South
29 sept. 2022 10h50 HE
|
National AIDS Memorial
Jackson, MS, Sept. 29, 2022 (GLOBE NEWSWIRE) -- Emmy-Award winning actress Sheryl Lee Ralph joined together with Mississippi HIV/AIDS community leaders and advocates to launch the first major...
National AIDS Memorial Releases Newest Mini-Documentary: “The Black Community & AIDS”
22 sept. 2022 13h49 HE
|
National AIDS Memorial
SAN FRANCISCO, California, Sept. 22, 2022 (GLOBE NEWSWIRE) -- The National AIDS Memorial has released its latest mini-documentary, “The Black Community & AIDS,” the seventh film in its oral...
CRISPR Gene Editing Market Size is projected to reach USD 14.80 Billion by 2030, growing at a CAGR of 29.80%: Straits Research
01 août 2022 12h40 HE
|
Straits Research
New York, United States, Aug. 01, 2022 (GLOBE NEWSWIRE) -- CRISPR Gene Editing, also called genome editing, modifies an organism's DNA. This method replaces, adds, or removes genetic material from...
AIDSVu Releases New Data Showing Significant Inequities in PrEP Use Among Black and Hispanic Americans
29 juil. 2022 12h30 HE
|
AIDSVu
ATLANTA, July 29, 2022 (GLOBE NEWSWIRE) -- Today, AIDSVu released the first-ever publicly available state-level PrEP use data and maps by race/ethnicity from 2012 to 2021, showing that while PrEP...
Les données sur Trogarzo(MD) présentées à la conférence AIDS 2022 par Theratechnologies démontrent la possibilité d’améliorer les schémas thérapeutiques
28 juil. 2022 11h19 HE
|
Theratechnologies
Une nouvelle sous-analyse des données sur des patients ayant participé à un essai clinique sur Trogarzo démontre que la suppression virale à long terme n’est pas influencée par des agents...
Theratechnologies Trogarzo® Data at AIDS 2022 Shows Potential for Improved Treatment Regimens
28 juil. 2022 11h19 HE
|
Theratechnologies
New sub-analysis on Trogarzo clinical trial patients demonstrates that long-term viral suppression is not influenced by partially active agents. Predictive pharmacokinetic modelling shows that new...
'I Can't Wait' is the Campaign Theme for World Hepatitis Day 2022
28 juil. 2022 00h15 HE
|
World Hepatitis Alliance
LONDON, England, July 28, 2022 (GLOBE NEWSWIRE) -- Today, World Hepatitis Day (WHD) launches with the campaign theme 'I Can't Wait'. On WHD, the World Hepatitis Alliance (WHA) joins together with...
Societal CDMO Selected To Provide Tech Transfer And Manufacturing Services To Support Clinical Development Of An Oral Solid Dose Product In Europe
20 juil. 2022 07h00 HE
|
Societal CDMO, Inc.
SAN DIEGO and GAINESVILLE, Ga., July 20, 2022 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO”; NASD: SCTL), a contract development and manufacturing organization (CDMO) dedicated to solving...
WCG Cares Unveils Rebrand, Changes Name to Catalyst Global
14 juil. 2022 12h00 HE
|
Catalyst Global
CARLSBAD, Calif., July 14, 2022 (GLOBE NEWSWIRE) -- WCG Cares, an international non-profit organization committed to increasing access to critical sexual and reproductive health (SRH) products and...
Immunocore announces dosing of first patient with ImmTAV® bispecific for HIV
11 juil. 2022 07h00 HE
|
Immunocore Holdings Limited
PRESS RELEASE Immunocore announces dosing of first patient with ImmTAV® bispecific for HIV IMC-M113V, T cell receptor bispecific, targets an HIV Gag antigen Single Ascending Dose portion of Phase...